VTVT
vTv Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.80
+1.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 377.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.60x
- Price / sales
- 3.41x
- Price / cash flow
- -7.50x
Enterprise value
- Enterprise value
- $39.1M
- EV / sales
- 1.06x
- EV / EBITDA
- -6.12x
- EV / EBIT
- -4.23x
- Market cap
- $125.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026